tiprankstipranks
CVS Health Corp (CH:CVS)
:CVS
Switzerland Market

CVS Health (CVS) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

CVS Analyst Ratings

Strong Buy
17Ratings
Strong Buy
16 Buy
1 Hold
0 Sell
Based on 17 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CVS Stock 12 Month Forecast

Average Price Target

Based on 17 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is CHF92.52 with a high forecast of CHF102.26 and a low forecast of CHF83.60. The average price target represents a change from the last price of .
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
Highest Price TargetCHF102.26Average Price TargetCHF92.52Lowest Price TargetCHF83.60
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:CVS
J.P. Morgan
J.P. Morgan
CHF90.09CHF95.77
Buy
Reiterated
08/12/26
J.P. Morgan Remains a Buy on CVS Health (CVS)
Bernstein Analyst forecast on CH:CVS
Bernstein
Bernstein
CHF86.03
Buy
Reiterated
08/12/26
Bernstein Keeps Their Buy Rating on CVS Health (CVS)
Wells Fargo Analyst forecast on CH:CVS
Wells Fargo
Wells Fargo
CHF99.83
Buy
Assigned
08/11/26
Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)
Morgan Stanley Analyst forecast on CH:CVS
Morgan Stanley
Morgan Stanley
CHF90.09
Buy
Assigned
08/10/26
Morgan Stanley Keeps Their Buy Rating on CVS Health (CVS)
TD Cowen
CHF89.28
Buy
Reiterated
08/10/26
CVS Health: Buy Rating Reaffirmed as Strong Earnings Outlook and Segment Outperformance Support Unchanged $110 Price Target
Truist Financial Analyst forecast on CH:CVS
Truist Financial
Truist Financial
CHF95.77
Buy
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), CVS Health (NYSE: CVS) and Sarepta Therapeutics (NASDAQ: SRPT)
RBC Capital Analyst forecast on CH:CVS
RBC Capital
RBC Capital
CHF91.71
Buy
Reiterated
08/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
UBS
CHF99.02CHF102.26
Buy
Reiterated
08/06/26
CVS Health price target raised to $126 from $122 at UBSCVS Health price target raised to $126 from $122 at UBS
Evercore ISI
CHF105.51CHF101.45
Buy
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on CH:CVS
Robert W. Baird
Robert W. Baird
CHF76.29CHF86.84
Buy
Reiterated
08/06/26
CVS Health price target raised to $107 from $94 at BairdCVS Health price target raised to $107 from $94 at Baird
Barclays
CHF86.03CHF87.65
Buy
Reiterated
08/06/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Bank of America Securities Analyst forecast on CH:CVS
Bank of America Securities
Bank of America Securities
CHF97.39
Buy
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Envista Holdings (NVST), Vaxcyte (PCVX)
Goldman Sachs Analyst forecast on CH:CVS
Goldman Sachs
Goldman Sachs
CHF84.41CHF94.15
Buy
Reiterated
07/27/26
Goldman Sachs Remains a Buy on CVS Health (CVS)
Mizuho Securities Analyst forecast on CH:CVS
Mizuho Securities
Mizuho Securities
CHF93.34CHF97.39
Buy
Reiterated
07/13/26
Mizuho Securities Keeps Their Buy Rating on CVS Health (CVS)
Cantor Fitzgerald Analyst forecast on CH:CVS
Cantor Fitzgerald
Cantor Fitzgerald
CHF81.16CHF89.28
Buy
Reiterated
07/07/26
CVS Health price target raised to $110 from $100 at Cantor FitzgeraldCVS Health price target raised to $110 from $100 at Cantor Fitzgerald
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:CVS
J.P. Morgan
J.P. Morgan
CHF90.09CHF95.77
Buy
Reiterated
08/12/26
J.P. Morgan Remains a Buy on CVS Health (CVS)
Bernstein Analyst forecast on CH:CVS
Bernstein
Bernstein
CHF86.03
Buy
Reiterated
08/12/26
Bernstein Keeps Their Buy Rating on CVS Health (CVS)
Wells Fargo Analyst forecast on CH:CVS
Wells Fargo
Wells Fargo
CHF99.83
Buy
Assigned
08/11/26
Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)
Morgan Stanley Analyst forecast on CH:CVS
Morgan Stanley
Morgan Stanley
CHF90.09
Buy
Assigned
08/10/26
Morgan Stanley Keeps Their Buy Rating on CVS Health (CVS)
TD Cowen
CHF89.28
Buy
Reiterated
08/10/26
CVS Health: Buy Rating Reaffirmed as Strong Earnings Outlook and Segment Outperformance Support Unchanged $110 Price Target
Truist Financial Analyst forecast on CH:CVS
Truist Financial
Truist Financial
CHF95.77
Buy
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Agilon Health (NYSE: AGL), CVS Health (NYSE: CVS) and Sarepta Therapeutics (NASDAQ: SRPT)
RBC Capital Analyst forecast on CH:CVS
RBC Capital
RBC Capital
CHF91.71
Buy
Reiterated
08/06/26
RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)
UBS
CHF99.02CHF102.26
Buy
Reiterated
08/06/26
CVS Health price target raised to $126 from $122 at UBSCVS Health price target raised to $126 from $122 at UBS
Evercore ISI
CHF105.51CHF101.45
Buy
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on CH:CVS
Robert W. Baird
Robert W. Baird
CHF76.29CHF86.84
Buy
Reiterated
08/06/26
CVS Health price target raised to $107 from $94 at BairdCVS Health price target raised to $107 from $94 at Baird
Barclays
CHF86.03CHF87.65
Buy
Reiterated
08/06/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Bank of America Securities Analyst forecast on CH:CVS
Bank of America Securities
Bank of America Securities
CHF97.39
Buy
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Envista Holdings (NVST), Vaxcyte (PCVX)
Goldman Sachs Analyst forecast on CH:CVS
Goldman Sachs
Goldman Sachs
CHF84.41CHF94.15
Buy
Reiterated
07/27/26
Goldman Sachs Remains a Buy on CVS Health (CVS)
Mizuho Securities Analyst forecast on CH:CVS
Mizuho Securities
Mizuho Securities
CHF93.34CHF97.39
Buy
Reiterated
07/13/26
Mizuho Securities Keeps Their Buy Rating on CVS Health (CVS)
Cantor Fitzgerald Analyst forecast on CH:CVS
Cantor Fitzgerald
Cantor Fitzgerald
CHF81.16CHF89.28
Buy
Reiterated
07/07/26
CVS Health price target raised to $110 from $100 at Cantor FitzgeraldCVS Health price target raised to $110 from $100 at Cantor Fitzgerald
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

3 Months
Stephen BaxterWells Fargo
Success Rate
13/19 ratings generated profit
68%
Average Return
+12.54%
Copying Stephen Baxter's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +12.54% per trade.
1 Year
Stephen BaxterWells Fargo
Success Rate
16/19 ratings generated profit
84%
Average Return
+28.84%
Copying Stephen Baxter's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +28.84% per trade.
2 Years
Allen LutzBank of America Securities
Success Rate
24/27 ratings generated profit
89%
Average Return
+36.26%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +36.26% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVS Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
22
33
34
37
30
Hold
1
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
33
34
38
31
In the current month, CVS has received 30 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CVS average Analyst price target in the past 3 months is 92.52.
Each month's total comprises the sum of three months' worth of ratings.

CVS Financial Forecast

CVS Earnings Forecast

Next quarter’s earnings estimate for CVS is CHF1.34 with a range of CHF1.18 to CHF1.57. The previous quarter’s EPS was CHF2.09. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 42.69% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s earnings estimate for CVS is CHF1.34 with a range of CHF1.18 to CHF1.57. The previous quarter’s EPS was CHF2.09. CVS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 42.69% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Sales Forecast

Next quarter’s sales forecast for CVS is CHF84.71B with a range of CHF83.07B to CHF88.07B. The previous quarter’s sales results were CHF86.12B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.00% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.
Next quarter’s sales forecast for CVS is CHF84.71B with a range of CHF83.07B to CHF88.07B. The previous quarter’s sales results were CHF86.12B. CVS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.00% of the time in the same period. In the last calendar year CVS has Performed in-line its overall industry.

CVS Stock Forecast FAQ

What is CH:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 92.52.
    What is CH:CVS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:CVS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CVS Health Corp a Buy, Sell or Hold?
        CVS Health Corp has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
          What is CVS Health Corp’s share price target?
          The average share price target for CVS Health Corp is 92.52. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF102.26 ,and the lowest forecast is CHF83.60. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about CVS Health Corp?
            CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
              How can I buy shares of CVS Health Corp?
              To buy shares of CH:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.